|
1
|
Li Y, Wang XQ, Zhang L, Lv XD, Su X, Tian
S, Liu CM, Ma X and Xia HF: A SNP in pri-miR-10a is associated with
recurrent spontaneous abortion in a Han-Chinese population.
Oncotarget. 7:8208–8222. 2016.PubMed/NCBI
|
|
2
|
Mei S, Tan J, Chen H, Chen Y and Zhang J:
Changes of CD4+CD25high regulatory T cells and FOXP3 expression in
unexplained recurrent spontaneous abortion patients. Fertil Steril.
94:2244–2247. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang WJ, Liu FJ, Qu HM, Hao CF, Qu QL,
Xiong-Wang Bao HC and Wang XR: Regulation of the expression of Th17
cells and regulatory T cells by IL-27 in patients with unexplained
early recurrent miscarriage. J Reprod Immunol. 99:39–45. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Raghupathy R, Makhseed M, Azizieh F,
Hassan N, Al-Azemi M and Al-Shamali E: Maternal Th1- and Th2-type
reactivity to placental antigens in normal human pregnancy and
unexplained recurrent spontaneous abortions. Cell Immunol.
196:122–130. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang WJ, Hao CF, Yi-Lin Yin GJ, Bao SH,
Qiu LH and Lin QD: Increased prevalence of T helper 17 (Th17) cells
in peripheral blood and decidua in unexplained recurrent
spontaneous abortion patients. J Reprod Immunol. 84:164–170. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sereshki N, Gharagozloo M, Ostadi V,
Ghahiri A, Roghaei MA, Mehrabian F, Andalib AA, Hassanzadeh A,
Hosseini H and Rezaei A: Variations in T-helper 17 and regulatory T
cells during the menstrual cycle in peripheral blood of women with
recurrent spontaneous abortion. Int J Fertil Steril. 8:59–66.
2014.PubMed/NCBI
|
|
7
|
Wu L, Luo LH, Zhang YX, Li Q, Xu B, Zhou
GX, Luan HB and Liu YS: Alteration of Th17 and Treg cells in
patients with unexplained recurrent spontaneous abortion before and
after lymphocyte immunization therapy. Reprod Biol Endocrinol.
12:742014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hutton B, Sharma R, Fergusson D, Tinmouth
A, Hebert P, Jamieson J and Walker M: Use of intravenous
immunoglobulin for treatment of recurrent miscarriage: a systematic
review. BJOG. 114:134–142. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Moraru M, Carbone J, Alecsandru D,
Castillo-Rama M, García-Segovia A, Gil J, Alonso B, Aguarón A,
Ramos-Medina R, Martínez de María J, et al: Intravenous
immunoglobulin treatment increased live birth rate in a Spanish
cohort of women with recurrent reproductive failure and expanded
CD56(+) cells. Am J Reprod Immunol. 68:75–84. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang X, Liu FM, Du Y, Ye Y and Fang P:
Combined intramuscular immunoglobulin and human chorionic
gonadotropin therapy for prevention of recurrent spontaneous
abortion. Acta Academiae Medicinae Xuzhou. 17:368–370. 1997.(In
Chinese).
|
|
11
|
Loong CC, Hsieh HG, Lui WY, Chen A and Lin
CY: Evidence for the early involvement of interleukin 17 in human
and experimental renal allograft rejection. J Pathol. 197:322–332.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ma L, Zhang H, Hu K, Lv G, Fu Y, Ayana DA,
Zhao P and Jiang Y: The imbalance between Tregs, Th17 cells and
inflammatory cytokines among renal transplant recipients. BMC
Immunol. 16:562015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nakashima A, Ito M, Yoneda S, Shiozaki A,
Hidaka T and Saito S: Circulating and decidual Th17 cell levels in
healthy pregnancy. Am J Reprod Immunol. 63:104–109. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nakashima A, Ito M, Shima T, Bac ND,
Hidaka T and Saito S: Accumulation of IL-17-positive cells in
decidua of inevitable abortion cases. Am J Reprod Immunol. 64:4–11.
2010.PubMed/NCBI
|
|
15
|
Qin XJ, Liu FM and Liu XY: Expression and
significance of IL-17A, NF-κB and PR in uterine decidua of
unexplained early spontaneous abortion patients. Acta Academiae
Medicinae Xuzhou. 33:132–135. 2013.(In Chinese).
|
|
16
|
Paust S and Cantor H: Regulatory T cells
and autoimmune disease. Immunol Rev. 204:195–207. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Somerset DA, Zheng Y, Kilby MD, Sansom DM
and Drayson MT: Normal human pregnancy is associated with an
elevation in the immune suppressive CD25+ CD4+ regulatory T-cell
subset. Immunology. 112:38–43. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Arruvito L, Sanz M, Banham AH and Fainboim
L: Expansion of CD4+CD25+ and FOXP3+ regulatory T cells during the
follicular phase of the menstrual cycle: implications for human
reproduction. J Immunol. 178:2572–2578. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu YS, Wu L, Tong XH, Wu LM, He GP, Zhou
GX, Luo LH and Luan HB: Study on the relationship between Th17
cells and unexplained recurrent spontaneous abortion. Am J Reprod
Immunol. 65:503–511. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zenclussen AC, Gerlof K, Zenclussen ML,
Ritschel S, Bertoja A Zambon, Fest S, Hontsu S, Ueha S, Matsushima
K, Leber J, et al: Regulatory T cells induce a privileged tolerant
microenvironment at the fetal-maternal interface. Eur J Immunol.
36:82–94. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang H, Liu FM, Liu XY and Zhu XW: The
effect of hCG bind immunoglobin G on maternal-fetal interface's
Th1/Th2 type cytokines and pregnancy's outcome of abortion model.
Chinese J Birth Health Heredity. 21:53–55. 2013.(In Chinese).
|
|
22
|
Bai H, Pan J, Jia X and Huang H: The
inhibition effect of human chorionic gonadotropin(hCG) on mRNA
expression of cytokines initiated inflammatory reaction. Chinese J
Immunol. 19:193–203. 2003.(In Chinese).
|
|
23
|
Kimura A and Kishimoto T: IL-6: regulator
of Treg/Th17 balance. Eur J Immunol. 40:1830–1835. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schumacher A, Brachwitz N, Sohr S,
Engeland K, Langwisch S, Dolaptchieva M, Alexander T, Taran A,
Malfertheiner SF, Costa SD, et al: Human chorionic gonadotropin
attracts regulatory T cells into the fetal-maternal interface
during early human pregnancy. J Immunol. 182:5488–5497. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Carp HJ, Achiron R, Toder V and Mashiach
S: Intravenous immunoglobulin in the prevention of recurrent
miscarriage. Br J Obstet Gynaecol. 102:509–510. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Coulam CB, Krysa L, Stern JJ and Bustillo
M: Intravenous immunoglobulin for treatment of recurrent pregnancy
loss. Am J Reprod Immunol. 34:333–337. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Christiansen OB, Pedersen B, Rosgaard A
and Husth M: A randomized, double-blind, placebo-controlled trial
of intravenous immunoglobulin in the prevention of recurrent
miscarriage: evidence for a therapeutic effect in women with
secondary recurrent miscarriage. Hum Reprod. 17:809–816. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Winger EE and Reed JL: Treatment with
tumor necrosis factor inhibitors and intravenous immunoglobulin
improves live birth rates in women with recurrent spontaneous
abortion. Am J Reprod Immunol. 60:8–16. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim DJ, Lee SK, Kim JY, Na BJ, Hur SE, Lee
M and Kwak-Kim J: Intravenous immunoglobulin G modulates peripheral
blood Th17 and Foxp3(+) regulatory T cells in pregnant women with
recurrent pregnancy loss. Am J Reprod Immunol. 71:441–450. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Clark DA: Immunological factors in
pregnancy wastage: fact or fiction. Am J Reprod Immunol.
59:277–300. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Maddur MS, Vani J, Hegde P,
Lacroix-Desmazes S, Kaveri SV and Bayry J: Inhibition of
differentiation, amplification, and function of human TH17 cells by
intravenous immunoglobulin. J Allergy Clin Immunol.
127:823–830.e1-7. 2011. View Article : Google Scholar : PubMed/NCBI
|
